FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022045242> ?p ?o ?g. }

• W2022045242 endingPage "96" @default.
• W2022045242 startingPage "96" @default.
• W2022045242 abstract "Plasmodium vivax malaria resistant to chloroquine is alarming in Indonesia and has been also reported in other countries. An alternative drug is needed. The study was a prospective evaluation and a comparative study of the therapeutic efficacy of chloroquine 25 mg base/kg bw for 3 days (CQ3, n=75), CQ3 plus sulfadoxine-pyrimethamine based on pyrimethamine dosage of 1.25 mg/kg bw single dose (SP1) [CQ3+SP1, n=84] and amodiaquine 25 mg base/kg bw for 3 days (AQ3, n=83) in symptomatic vivax malaria patients in children and adults. The new version of 2001 WHO test system was used in this study. PCR for genotyping was also done to validate and confirm the treatment outcomes. The therapeutic efficacy of CQ3, CQ3+SP1 and AQ3 on day 14 were very high (94.4%, 97.4% and 98.8%), and dropped on day 28 (81.7%, 87.2% and 96.2% by evaluable analysis; 78.9%. 82.0% and 92.5% after confirmation with PCR; and 74.7%, 78.0% and 90.2% by intention to treat analysis). Most of the ACPR cases (>96%) showed hematological recovery. Gametocyte carriages were documented on day 7 (2.9%, 1.3% and 1.2%), day 14 (4.3%, 1.3% and 1.2%) and day 28 (6.6%, 4.2% and none) in CQ3, CQ3+SP1 and AQ3 groups. Of these 3 regimens, AQ3 showed a better therapeutic efficacy than CQ3 and combined CQ3+SP1 by day 28. Introducing primaquine at the beginning of treatment day or giving a radical treatment in vivax malaria may improve the cure rate. (Med J Indones 2008; 17: 96-106)" @default.
• W2022045242 created "2016-06-24" @default.
• W2022045242 creator A5013207644 @default.
• W2022045242 creator A5015201460 @default.
• W2022045242 creator A5020224633 @default.
• W2022045242 creator A5029673281 @default.
• W2022045242 creator A5035357750 @default.
• W2022045242 creator A5049427727 @default.
• W2022045242 creator A5062080022 @default.
• W2022045242 creator A5070012486 @default.
• W2022045242 creator A5078845729 @default.
• W2022045242 creator A5079667105 @default.
• W2022045242 date "2008-05-01" @default.
• W2022045242 modified "2023-10-18" @default.
• W2022045242 title "Efficacy of chloroquine, chloroquine plus sulphadoxine-pyrimethamine, and amodiaquine for treatment of vivax malaria in Bangka island, Indonesia: a randomized trial" @default.
• W2022045242 cites W1787200933 @default.
• W2022045242 cites W1907903993 @default.
• W2022045242 cites W1967241970 @default.
• W2022045242 cites W1967956040 @default.
• W2022045242 cites W1973318954 @default.
• W2022045242 cites W1977699814 @default.
• W2022045242 cites W1978939743 @default.
• W2022045242 cites W2007154151 @default.
• W2022045242 cites W2031526955 @default.
• W2022045242 cites W2048350387 @default.
• W2022045242 cites W2049122105 @default.
• W2022045242 cites W2099411632 @default.
• W2022045242 cites W2105394863 @default.
• W2022045242 cites W2166261288 @default.
• W2022045242 cites W2171880743 @default.
• W2022045242 cites W2180361176 @default.
• W2022045242 cites W2470744053 @default.
• W2022045242 cites W2581663931 @default.
• W2022045242 cites W2658704392 @default.
• W2022045242 doi "https://doi.org/10.13181/mji.v17i2.307" @default.
• W2022045242 hasPublicationYear "2008" @default.
• W2022045242 type Work @default.
• W2022045242 sameAs 2022045242 @default.
• W2022045242 citedByCount "3" @default.
• W2022045242 countsByYear W20220452422014 @default.
• W2022045242 countsByYear W20220452422016 @default.
• W2022045242 countsByYear W20220452422022 @default.
• W2022045242 crossrefType "journal-article" @default.
• W2022045242 hasAuthorship W2022045242A5013207644 @default.
• W2022045242 hasAuthorship W2022045242A5015201460 @default.
• W2022045242 hasAuthorship W2022045242A5020224633 @default.
• W2022045242 hasAuthorship W2022045242A5029673281 @default.
• W2022045242 hasAuthorship W2022045242A5035357750 @default.
• W2022045242 hasAuthorship W2022045242A5049427727 @default.
• W2022045242 hasAuthorship W2022045242A5062080022 @default.
• W2022045242 hasAuthorship W2022045242A5070012486 @default.
• W2022045242 hasAuthorship W2022045242A5078845729 @default.
• W2022045242 hasAuthorship W2022045242A5079667105 @default.
• W2022045242 hasBestOaLocation W20220452421 @default.
• W2022045242 hasConcept C104317684 @default.
• W2022045242 hasConcept C126322002 @default.
• W2022045242 hasConcept C135763542 @default.
• W2022045242 hasConcept C203014093 @default.
• W2022045242 hasConcept C2776793103 @default.
• W2022045242 hasConcept C2776992834 @default.
• W2022045242 hasConcept C2777035104 @default.
• W2022045242 hasConcept C2777425658 @default.
• W2022045242 hasConcept C2778048844 @default.
• W2022045242 hasConcept C2778301690 @default.
• W2022045242 hasConcept C2778371730 @default.
• W2022045242 hasConcept C2779997623 @default.
• W2022045242 hasConcept C31467283 @default.
• W2022045242 hasConcept C55493867 @default.
• W2022045242 hasConcept C556039675 @default.
• W2022045242 hasConcept C71924100 @default.
• W2022045242 hasConcept C86803240 @default.
• W2022045242 hasConcept C90924648 @default.
• W2022045242 hasConcept C98274493 @default.
• W2022045242 hasConcept C99389464 @default.
• W2022045242 hasConceptScore W2022045242C104317684 @default.
• W2022045242 hasConceptScore W2022045242C126322002 @default.
• W2022045242 hasConceptScore W2022045242C135763542 @default.
• W2022045242 hasConceptScore W2022045242C203014093 @default.
• W2022045242 hasConceptScore W2022045242C2776793103 @default.
• W2022045242 hasConceptScore W2022045242C2776992834 @default.
• W2022045242 hasConceptScore W2022045242C2777035104 @default.
• W2022045242 hasConceptScore W2022045242C2777425658 @default.
• W2022045242 hasConceptScore W2022045242C2778048844 @default.
• W2022045242 hasConceptScore W2022045242C2778301690 @default.
• W2022045242 hasConceptScore W2022045242C2778371730 @default.
• W2022045242 hasConceptScore W2022045242C2779997623 @default.
• W2022045242 hasConceptScore W2022045242C31467283 @default.
• W2022045242 hasConceptScore W2022045242C55493867 @default.
• W2022045242 hasConceptScore W2022045242C556039675 @default.
• W2022045242 hasConceptScore W2022045242C71924100 @default.
• W2022045242 hasConceptScore W2022045242C86803240 @default.
• W2022045242 hasConceptScore W2022045242C90924648 @default.
• W2022045242 hasConceptScore W2022045242C98274493 @default.
• W2022045242 hasConceptScore W2022045242C99389464 @default.
• W2022045242 hasLocation W20220452421 @default.
• W2022045242 hasLocation W20220452422 @default.
• W2022045242 hasOpenAccess W2022045242 @default.
• W2022045242 hasPrimaryLocation W20220452421 @default.

• next